Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected small hepatocellular carcinomas

Hepatobiliary and Pancreatic Diseases International

Volumn 9, Issue 3, 2010, Pages 296-305

  Long, Jiang ^a,b   Lang, Zhen Wei ^b   Wang, Hua Guang ^c   Wang, Tai Ling ^d   Wang, Bao En ^a   Liu, Si Qi ^e  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^e INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

Glutamine synthetase; Phenazine biosynthesis like domain containing protein; Proteomics

Indexed keywords

GLUTAMATE AMMONIA LIGASE; PHENAZINE; PBLD PROTEIN, HUMAN; PROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DONOR; DOWN REGULATION; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEOMICS; TIME OF FLIGHT MASS SPECTROMETRY; TWO DIMENSIONAL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING; BLOOD; CARCINOMA, HEPATOCELLULAR; CHI SQUARE DISTRIBUTION; ENZYMOLOGY; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MASS SPECTROMETRY; MIDDLE AGED; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADULT; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CHI-SQUARE DISTRIBUTION; DOWN-REGULATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUTAMATE-AMMONIA LIGASE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROTEINS; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 77953848895     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Mendizabal M, Reddy KR. Current management of hepatocellular carcinoma. Med Clin North Am 2009;93:885-900, viii.
2. Pawlotsky JM, Cocquerel L, Durantel D, Lavillette D, Lerat H, Pécheur EI, et al. HCV research 20 years after discovery: a summary of the 16th international symposium on hepatitis C virus and related viruses. Gastroenterology 2010;138:6-12.
3. Seow TK, Liang RC, Leow CK, Chung MC. Hepatocellular carcinoma: from bedside to proteomics. Proteomics 2001;1: 1249-1263.
4. Zhou XD, Tang ZY, Yang BH, Lin ZY, Ma ZC, Ye SL, et al. Experience in one thousand hepatectomy for small hepatocellular carcinoma. Zhong Guo Shi Yong Wai Ke Za Zhi 2001;21:41-44.
5. Li N, Zhang J, Liang Y, Shao J, Peng F, Sun M, et al. A controversial tumor marker: is SM22 a proper biomarker for gastric cancer cells? J Proteome Res 2007;6:3304-3312.
6. Oka H, Tamori A, Kuroki T, Kobayashi K, Yamamoto S. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology 1994;19:61-66.
7. Blanc JF, Lalanne C, Plomion C, Schmitter JM, Bathany K, Gion JM, et al. Proteomic analysis of differentially expressed proteins in hepatocellular carcinoma developed in patients with chronic viral hepatitis C. Proteomics 2005;5:3778-3789.
8. Feng JT, Liu YK, Song HY, Dai Z, Qin LX, Almofti MR, et al. Heat-shock protein 27: a potential biomarker for hepatocellular carcinoma identified by serum proteome analysis. Proteomics 2005;5:4581-4588.
9. Li C, Tan YX, Zhou H, Ding SJ, Li SJ, Ma DJ, et al. Proteomic analysis of hepatitis B virus-associated hepatocellular carcinoma: Identification of potential tumor markers. Proteomics 2005;5:1125-1139.
10. Bioulac-Sage P, Laumonier H, Rullier A, Cubel G, Laurent C, Zucman-Rossi J, et al. Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool insurgical pathology. Liver Int 2009;29:459-465.
11. Sun W, Xing B, Sun Y, Du X, Lu M, Hao C, et al. Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues. Mol Cell Proteomics 2007; 6:1798-1808.
12. Sun S, Lee NP, Poon RT, Fan ST, He QY, Lau GK, et al. Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways. Liver Int 2007;27: 1021-1038.
13. Brosnan ME, Brosnan JT. Hepatic glutamate metabolism: a tale of 2 hepatocytes. Am J Clin Nutr 2009;90:857S-861S.
14. Gebhardt R, Baldysiak-Figiel A, Krügel V, Ueberham E, Gaunitz F. Hepatocellular expression of glutamine synthetase: an indicatorof morphogen actions as master regulators of zonation in adult liver. Prog Histochem Cytochem 2007;41:201-266.
15. Haussinger D, Schliess F. Glutamine metabolism and signaling in the liver. Front Biosci 2007;12:371-391.
16. Poyck PP, Hoekstra R, Vermeulen JL, van Wijk AC, Chamuleau RA, Hakvoort TB, et al. Expression of glutamine synthetase and carbamoylphosphate synthetase i in a bioartificial liver: markers for the development of zonation in vitro. Cells Tissues Organs 2008;188:259-269.
17. Malarkey DE, Johnson K, Ryan L, Boorman G, Maronpot RR. New insights into functional aspects of liver morphology. Toxicol Pathol 2005;33:27-34.
18. Apte U, Singh S, Zeng G, Cieply B, Virji MA, Wu T, et al. Beta-catenin activation promotes liver regeneration after acetaminophen-induced injury. Am J Pathol 2009;175:1056-1065.
19. Medina MA. Glutamine and cancer. J Nutr 2001;131:2539S- 2542S.
20. Parry-Billings M, Leighton B, Dimitriadis GD, Curi R, Bond J, Bevan S, et al. The effect of tumour bearing on skeletal muscle glutamine metabolism. Int J Biochem 1991;23:933-937.
21. Souba WW. Glutamine and cancer. Ann Surg 1993;218:715-728.
22. Kaiser S, Gerok W, Haussinger D. Ammonia and glutamine metabolism in human liver slices: new aspects on the pathogenesis of hyperammonaemia in chronic liver disease. Eur J Clin Invest 1988;18:535-542.
23. Yang C, Sudderth J, Dang T, Bachoo RM, McDonald JG, DeBerardinis RJ. Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling. Cancer Res 2009;69:7986-7993.
24. Dang CV. MYC, microRNAs and glutamine addiction in cancers. Cell Cycle 2009;8:3243-3245.
25. DeBerardinis RJ, Cheng T. Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene 2010;29:313-324.
26. Saitoh F, Araki T. Proteasomal degradation of glutamine synthetase regulates schwann cell differentiation. J Neurosci 2010;30:1204-1212.
27. Di Tommaso L, Destro A, Seok JY, Balladore E, Terracciano L, Sangiovanni A, et al. The application of markers (HSP70GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma. J Hepatol 2009;50:746-754.
28. Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Saric J, Sa Cunha A, et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 2007;46:740-748.
29. Cadoret A, Ovejero C, Terris B, Souil E, Lévy L, Lamers WH, et al. New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism. Oncogene 2002;21: 8293-8301.
30. Cieply B, Zeng G, Proverbs-Singh T, Geller DA, Monga SP. Unique phenotype of hepatocellular cancers with exon-3 mutations in beta-catenin gene. Hepatology 2009;49:821-831.
31. Behari J, Zeng G, Otruba W, Thompson MD, Muller P, Micsenyi A, et al. R-Etodolac decreases beta-catenin levels along with survival and proliferation of hepatoma cells. J Hepatol 2007;46:849-857.
32. Di Tommaso L, Franchi G, Park YN, Fiamengo B, Destro A, Morenghi E, et al. Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis. Hepatology 2007;45:725-734.
33. Sekine S, Gutiérrez PJ, Lan BY, Feng S, Hebrok M. Liverspecific loss of beta-catenin results in delayed hepatocyte proliferation after partial hepatectomy. Hepatology 2007;45: 361-368.
34. Tan X, Behari J, Cieply B, Michalopoulos GK, Monga SP. Conditional deletion of beta-catenin reveals its role in liver growth and regeneration. Gastroenterology 2006;131:1561-1572.
35. Schmidt LE, Dalhoff K. Alpha-fetoprotein is a predictor of outcome in acetaminophen-induced liver injury. Hepatology 2005;41:26-31.
36. Iriyama C, Matsuda S, Katsumata R, Hamaguchi M. Cloning and sequencing of a novel human gene which encodes a putative hydroxylase. J Hum Genet 2001;46:289-292. (Pubitemid 32410682)
37. Rebouissou S, Imbeaud S, Balabaud C, Boulanger V, Bertrand- Michel J, Tercé F, et al. HNF1alpha inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate-response element-binding protein (ChREBP) activation. J Biol Chem 2007;282:14437-14446.
38. Zhang J, Kang B, Tan X, Bai Z, Liang Y, Xing R, et al. Comparative analysis of the protein profiles from primary gastric tumors and their adjacent regions: MAWBP could be a new protein candidate involved in gastric cancer. J Proteome Res 2007;6:4423-4432.
39. Datta PK, Moses HL. STRAP and Smad7 synergize in the inhibition of transforming growth factor beta signaling. Mol Cell Biol 2000;20:3157-3167.